Notices
Essential Drugs Division
Re-tender for the procurement of drugs/supplies for the year 2024-25"vide Re-tender No. KMSCL/ED/III - VIII/RT/2024/016
Essential Drugs Division
KMSCL - E-tender for the Procurement of Drugs/ Supplies (Category III - VIII) for the year 2024-25 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published
Essential Drugs Division
List of selected/ rejected bidders for Price bid evaluation against the tender for the Procurement of Drugs for NVHCP for the year 2024-25
Essential Drugs Division
KMSCL- Re- tender for the Procurement of Drugs for the year 2024-25- Technical Bid Evaluation - defects noticed/ status- Published- reg
Essential Drugs Division
KMSCL- Re- tender for the Procurement of Specialty Drugs for the year 2024-25- Technical Bid Evaluation - defects noticed and status- Published- reg
Essential Drugs Division
Notice on Technical Bid Evaluaiton of tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24
Essential Drugs Division
E- Tender for the Procurement of Drugs for De-Addiction Centers for the year 2024-25
Essential Drugs Division
KMSCL- E-tender for the Procurement of Veterinary Medicines for the year 2023-24- Price Bid Evaluation - Notice on Supplier wise rate quoted and Provisional Bid Ranking Status - Published- reg
Essential Drugs Division
Final Bid Ranking Status of e-tender for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024-25
Essential Drugs Division
KMSCL-E- tender for the Procurement of Veterinary Medicines for the year 2023-24-Technical bid Evaluation- List of selected/rejected bidders products for price bid evaluation - Published -reg
Essential Drugs Division
E-tender for the Procurement of Recombinant Anti Haemophilic Factor VIII 1000 IU & 1500 IU for the year 2023-24- Price Bid Evaluation - Final Bid Status- Published - reg
Essential Drugs Division
KMSCL- E-tender for the procurement of Anti Cancer Drugs for the year 2024-25- Price Bid Evaluation - Items Deferred- Final Bid Status- Published - Reg
Essential Drugs Division
KMSCL- E-tender for the procurement of Drugs/Supplies (Category III-VIII) for the year 2024-25- Price Bid Evaluation - Final Bid Status- published- reg
Essential Drugs Division
KMSCL-E- Tender for the procurement of Anti Retroviral Drugs for KSACS for the year 2024-25 - Price bid evaluation - Provisional Bid Ranking Status- Published- reg
Essential Drugs Division
Final Bid ranking Status Published for the Procurement of Vitamin A Oral Solution IP for the year 2023-24
Essential Drugs Division
List of selected/ rejected bidders for Price bid evaluation for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024-25
Essential Drugs Division
KMSCL- Re-tender for the Procurement of BIOLARVICIDE:BACILLUS THURINGIENSIS ISRAELIENSIS (BTI) For NVBDCP for the year 2023-24.
Essential Drugs Division
KMSCL- e- tender Document for the procurement of Veterinary Medicines for the year 2023-24 Technical Bid Evaluation - Defects noticed/ status - Published - reg
Essential Drugs Division
e-tender for the Procurement of Drugs/ Supplies (Category III - VIII) for the year 2024-25 - Supplier wise rate quoted and Provisional bid status - Publishing
Essential Drugs Division
KMSCL- E-Tender for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024 - 25- Technical Bid Evaluation - Defects noticed/ status - Published
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Corrigendum published
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Published
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Published
Essential Drugs Division
Cancellation of tender -e-tender for the procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 -5% AS for NVBDCP for the year 2023-24
Essential Drugs Division
Notice on Provisional Bid ranking status of E- Tender for the Procurement of Vitamin A Oral Solution IP for the year 2023-24
Essential Drugs Division
e- Tender for the Procurement of Drugs for Anemia Mukt Bharat for the year 2023-24
Essential Drugs Division
E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Price Bid Evaluation – Final Bid Status– Published
Essential Drugs Division
e-tender for the Procurement of Drugs for De- Addiction Centers for the year 2024-25
Essential Drugs Division
List of selected/ rejected bidders for Price bid evaluation of Tender for the Procurement of Vitamin A Paediatric Oral Solution IP for the year 2023-24
Essential Drugs Division
E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation
Essential Drugs Division
e-tender for the procurement of drugs/supplies for the year 2024-25 - Technical bid evaluation -Defects noticed/status- Published
Essential Drugs Division
KMSCL- e- tender for the Procurement of Drugs for the year 2024- 25- Price Bid Evaluation - Items Deferred - Final Bid Status - Published- reg
Essential Drugs Division
KMSCL- E-tender for the Procurement of Speciality Drugs for the year 2024-25- Price Bid EValuation- items Deferred - Final Bid Status- Published- reg
Essential Drugs Division
KMSCL-E-tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation- Final Bid Status- Published- reg
Essential Drugs Division
KMSCL – E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Technical Bid Evaluation – Defects noticed and status
Essential Drugs Division
KMSCL – E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Technical Bid Evaluation – Defects noticed and status
Essential Drugs Division
Defects noticed/status of the tender for the Procurement of Vitamin A Paediatric Oral Solution IP for the year 2023-24
Essential Drugs Division
e -tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation - Notice on Supplier wise rate quoted and Provisional Bid Ranking Status- Publised- reg
Essential Drugs Division
E-tender for the Procurement of Specialty Drugs for the year 2024-25 – Price Bid Evaluation – Final Bid Status– Published
Essential Drugs Division
e-tender for the procurement of veterinary drugs for the year 2023-24 - Annexures - Word Format- published
Essential Drugs Division
e-ender for the procurement of ANTI RETROVIRAL DRUGS FOR KSACS for the year 2024-25
Essential Drugs Division
KMSCL – E-tender for the Procurement of Drugs for the year 2024-25 – Notice - Technical Bid Evaluation - List of selected/rejected bidders/products for price bid evaluation – Published
Essential Drugs Division
KMSCL – E-tender for the Procurement of Specialty Drugs for the year 2024-25 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
Re-tender for the Procurement of RECOMBINANT ANTI HAEMOPHILIC FACTOR VIII 250 IU & 500 IU for the year 2023-24
Essential Drugs Division
e-tender for the Procurement of Veterinary Medicines to the Animal Husbandry Department for the year 2023-24
Essential Drugs Division
List of selected/ rejected bidder for price bid evaluation-videe- tender No- KMSCL/ED/RC /STK/2023/013 dtd. 10-08-2023
Essential Drugs Division
e- tender for the Procurement of BIOLARVICIDE: BACILLUS THURINGIENSIS ISRAELIENSIS (BTI) FOR NVBDCP for the year 2023-2024
Essential Drugs Division
e-tender for the procurement& Supply of VITAMIN A ORAL SOLUTION IP for the year 2023-24.
Essential Drugs Division
Provisional Bid ranking status of Re-tender for the Procurement of Insecticides for NVBDCP & Plan fund for the year 2022-23 vide e-tender No- KMSCL/ED/INS-NVBDCP & PLAN/RC/2023/012 Dated 26.07.2023
Essential Drugs Division
e-tender for the procurement of drugs for the year 2024-25 - Notice on Technical Bid evaluation- Defects noticed/status - Amendment - Published
Essential Drugs Division
KMSCL- e -tender for the Procurement of Drugs for the year 2024-25- Tehnical Bid Evaluation - defects noticed/status- Published- reg
Essential Drugs Division
e- tender for the procurement of Speciality Drugs for the year 2024-25- Technical Bid Evaluation - Defects noticed and status - Published -reg
Essential Drugs Division
KMSCL- E- tender for the procurement of Recombinant Anti Haemophilic Factor VIII 1000 IU & 1500 IU for the year 2023-24 - Status of Technical Bid Evaluation - List of selected/ rejected bidder/ products for price bid evaluation- Published- reg
Essential Drugs Division
Notice on defects noted for rectification -Published-e-tender for the Procurement of Salt Testing Kit for the year 2023-24
Essential Drugs Division
E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25- Tender time extension- Amendment notice published
Essential Drugs Division
List of selected/ rejected bidder for price bid evaluation -Published against render for the Procurement of 3 HP Drugs for LTBI for the year 2023-24
Essential Drugs Division
e-tender for the procurement of Drugs for the year 2024-25- ANNEXURES- WORD FORMAT
Essential Drugs Division
e-tender for the procurement of Drugs/Supplies for the year 2024-25- ANNEXURES- WORD FORMAT
Essential Drugs Division
KMSCL – E-tender for the Procurement of Drugs for Rare Diseases for SATH under NPRD for the year 2023-24 – Technical Bid Evaluation – Defects noticed/status– Published
Essential Drugs Division
E-tender for the procurement of drugs for Rare Diseases for the year 2023-24 – Time Extension Notice – published
Essential Drugs Division
LIST OF ITEMS NOT HAVING ELIGIBLE BIDDERS AGAINST THE E-TENDERS FOR THE YEAR 2023-24
Essential Drugs Division
ë-tender for the Procurement of Recombinant AntiHaemophilic Factor VIII 250IU and 500IU for the year 2023-24 vide E-tender No. KMSCL/ED/HAEM/2023/017 dated 15.11.2023